Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbon Nanoparticles for Targeted Axillary Dissection in Breast Cancer
NCT07032220Active, not recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Dec 2024
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in breast cancer, sponsored by Fujian Medical University Union Hospital. Primary endpoints: Detection Rate of Targeted Axillary Dissection at 24 months, False Negative Rate of Targeted Axillary Dissection at 24 months and 1 more. Started Dec 2024; status: active, not recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07032220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032220.